Zobrazeno 1 - 10
of 243
pro vyhledávání: '"V. Blaton"'
Autor:
Inge Gies, K. De Waele, L. Van Gaal, F.R. Heller, Olivier S. Descamps, Etienne Sokal, Véronique Beauloye, P. Legat, Xavier Stéphenne, V. Blaton, A. Mangano, G. De Backer, Jean Ducobu, André Scheen, M-C Lebrethon, J.P. Panier, Michel Langlois, R. Rooman, Ernst Rietzschel, Sylvie Tenoutasse, Yvon Carpentier, C. de Beaufort, Erik Muls, Jean-Luc Balligand
Publikováno v:
Atherosclerosis, 218(2), 272-280. (2011).
Atherosclerosis
Atherosclerosis
Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual from birth onwards to severe hypercholesterolemia with the development of early cardiovascular disease, a clear consensus on the management of this disea
Publikováno v:
Clinica Chimica Acta. 307:169-173
Critical care testing in a point of care (POC) setting can be very demanding for the laboratory. Lack of continuous monitoring of the normal functioning of POC instruments leads to late response to technical problems, and frequently results in more c
Autor:
Paul Capel, M. Van der Planken, V. Blaton, Johan Smitz, M. De Waele, G. Leroux-Roels, Jan Verhaegen, Frans Gorus, L. Verbisten, P. De Mol
Publikováno v:
Acta Clinica Belgica. 52:407-441
Autor:
P. De Mol, G. Leroux-Roels, V. Blaton, P. Capel, M. De Waele, F. Gorus, J. Smitz, M. Van der Planken, L. Verbisten, J. Verhaegen
Publikováno v:
Acta Clinica Belgica. 51:279-303
Publikováno v:
European Respiratory Journal. 4:1033-1036
A case is presented of interstitial pneumonitis and pulmonary vasculitis ascribed to the ingestion of an L-tryptophan preparation. An unintended rechallenge supported the causal relationship. There was neither myalgia nor peripheral eosinophilia. Bro
Autor:
V. Blaton
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 67(2)
Increased levels of low‐density lipoprotein (LDL) cholesterol, systemic inflammation activity and oxidative stress are the risk factors in the development of cardiovascular diseases and LDL‐ox may ...
Autor:
G. T. Sanders, G. H. Beastall, K. P. Kohse, S. Zérah, R. Jansen, U. Köller, V. Blaton, E. Lund, M. Parviainen Parviainen, J. Charret, E. Gurr, H. Nicholou, D. Kenny, M. Pazzagli, M. Opp, H. Willems, M. do Carmo Martins, J. M. Queraltó, B. Landin, A. Yu, J. McMurray
Publikováno v:
Clinical Chemistry and Laboratory Medicine, 40, 196-204
Clinical Chemistry and Laboratory Medicine, 40, 2, pp. 196-204
Clinical Chemistry and Laboratory Medicine, 40, 2, pp. 196-204
Item does not contain fulltext The European Communities Confederation of Clinical Chemistry has been actively engaged in raising the level of clinical chemistry in the European Union. Closer contacts between the national societies for clinical chemis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c3ba3a97b77a340836a0bbadb0a1f5a
http://hdl.handle.net/2066/185502
http://hdl.handle.net/2066/185502
Autor:
V, Blaton
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 309(2)
The mission of the Federation of European Societies of Clinical Chemistry is to support and promote clinical chemistry and laboratory medicine in Europe, to aid communication between the International Federation of Clinical Chemistry and Laboratory M
Publikováno v:
Clinical chemistry and laboratory medicine. 38(4)
Promotion of the professional growth and development of specialists in the field of clinical chemistry in European countries, and harmonisation of quality assessment and accreditation procedures are listed among the main goals and activities of Feder
Autor:
B, Bousquet, P J, Brombacher, S, Zérah, G H, Beastall, V, Blaton, J, Charret, E, Gurr, M, Halpern, R T, Jansen, D, Kenny, K P, Kohse, U, Köller, E, Lund, J, McMurray, M, Opp, M, Parviainen, M, Pazzagli, J M, Queraltó, G, Sotiropoulou, G T, Sanders
Publikováno v:
Clinical chemistry and laboratory medicine. 37(11-12)